Wedbush Initiates Coverage On Climb Bio with Outperform Rating, Announces Price Target of $12
Benzinga Newsdesk 8 months ago
NewsPrice TargetInitiationAnalyst Ratings
Wedbush analyst Laura Chico initiates coverage on Climb Bio (NASDAQ:CLYM) with a Outperform rating and announces Price Target of $12.
Wedbush analyst Laura Chico initiates coverage on Climb Bio (NASDAQ:CLYM) with a Outperform rating and announces Price Target of $12.